Bausch + Lomb Corporation announced that Eduardo C. Alfonso, MD, and Steven H. Collis have been appointed to its board of directors. The appointments are effective Jan. 1, 2026, and following changes announced in August 2025, the board is now comprised of 10 directors.

Dr. Alfonso is an ophthalmologist and internationally recognized expert in corneal and external eye diseases. He serves as director of the Bascom Palmer Eye Institute and chair of the Department of Ophthalmology at the University of Miami Miller School of Medicine, and holds the Kathleen and Stanley J. Glaser Chair in Ophthalmology.

Collis became president and CEO of Cencora Inc., a pharmaceutical distribution and health care services company, in 2011 and served in that role through 2024. Under his leadership, the company rebranded from AmerisourceBergen to Cencora in 2023 to reflect its global reach. Collis then transitioned to executive chairman of the board until he stepped down in late 2025. He currently serves on the board of Elevance Health, a managed health care and insurance company.